ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,541Medicare Part D Prescriptions Filled, Including Refills

Rank: 235 out of 3647

$505K Total Retail Price of All Prescriptions

Rank: 1075 out of 3647

733 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
15% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 733 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

13% of this provider’s 733 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 18,782 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$26 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
LEVOTHYROXINE SODIUM 967 964 1 5
SIMVASTATIN 911 865 2 1
OMEPRAZOLE 806 778 3 3
AMLODIPINE BESYLATE 795 772 4 2
LISINOPRIL 719 686 5 4
FUROSEMIDE 458 440 6 8
GLIMEPIRIDE 448 416 7 45
PRAVASTATIN SODIUM 414 412 8 16
METOPROLOL TARTRATE 412 397 9 7
ATENOLOL 408 400 10 10
FOSINOPRIL SODIUM 381 363 11 241
METFORMIN HCL 356 354 12 6
HYDROCHLOROTHIAZIDE 349 349 13 9
CARVEDILOL 343 311 14 20
LOSARTAN POTASSIUM 338 338 15 11
TERAZOSIN HCL 320 312 16 103
ALLOPURINOL 296 294 17 37
METOPROLOL SUCCINATE 280 280 18 18
POTASSIUM CHLORIDE 276 274 19 24
ALPRAZOLAM 268 257 20 31
WARFARIN SODIUM 250 246 21 15
LOVASTATIN 247 243 22 21
ALENDRONATE SODIUM 246 230 23 23
HYDROCODONE-ACETAMINOPHEN 228 205 S3 24 12
ZOLPIDEM TARTRATE 223 221 25 14
FINASTERIDE 223 223 25 66
DOXAZOSIN MESYLATE 214 202 27 57
GABAPENTIN 201 200 28 17
TRIAMTERENE-HCTZ 196 196 29 58
SERTRALINE HCL 188 177 30 27
ENALAPRIL MALEATE 176 160 31 35
TEMAZEPAM 174 174 32 47
GLIPIZIDE 164 158 33 41
TAMSULOSIN HCL 161 160 34 28
JANTOVEN 159 154 35 140
LOSARTAN-HYDROCHLOROTHIAZIDE 157 157 36 48
RANITIDINE HCL 154 150 37 29
ATORVASTATIN CALCIUM 146 139 38 13
CLOPIDOGREL 144 141 39 26
AMOXICILLIN 143 136 40 133
PLAVIX 141 135 41 39
LISINOPRIL-HYDROCHLOROTHIAZIDE 129 118 42 36
PREDNISONE 127 119 43 43
GEMFIBROZIL 122 121 44 82
DIGOXIN 118 118 45 51
ATENOLOL-CHLORTHALIDONE 115 115 46 171
BACLOFEN 111 109 47 97
DONEPEZIL HCL 109 106 48 30
NIFEDIPINE ER 108 105 49 67
ISOSORBIDE MONONITRATE ER 104 98 50 56
CIPROFLOXACIN HCL 100 95 51 53
KLOR-CON M20 99 98 52 121
FLUTICASONE PROPIONATE 98 97 53 32
AZITHROMYCIN 94 87 54 34
FLUOXETINE HCL 89 62 55 68
METHYLPREDNISOLONE 86 77 56 78
VERAPAMIL ER 82 82 57 99
PANTOPRAZOLE SODIUM 82 81 57 38
TRAMADOL HCL 81 80 59 22
BETAMETHASONE DIPROPIONATE 78 75 60 311
BENAZEPRIL HCL 69 69 61 71
LORAZEPAM 69 69 61 73
HYDRALAZINE HCL 69 58 61 81
KLOR-CON 10 66 59 64 106
SULFAMETHOXAZOLE-TRIMETHOPRIM 65 62 65 110
OXYBUTYNIN CHLORIDE 64 63 66 107
DILTIAZEM ER 63 63 67 167
MELOXICAM 62 61 68 33
FAMOTIDINE 61 36 69 61
ADVAIR DISKUS 59 48 70 52
DIOVAN 58 53 71 40
TRIAMTERENE-HYDROCHLOROTHIAZID 56 56 72 223
POLYETHYLENE GLYCOL 3350 55 53 73 143
PROAIR HFA 55 50 73 62
NAPROXEN 55 55 73 70
AMIODARONE HCL 52 52 76 211
GLIPIZIDE ER 51 49 77 112
FOSINOPRIL-HYDROCHLOROTHIAZIDE 50 47 10 78 671
GALANTAMINE HBR 50 50 78 245
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 31, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.